Literature DB >> 9378234

Peripheral-type benzodiazepine receptors.

D M Zisterer1, D C Williams.   

Abstract

1. The pharmacological effects of benzodiazepines are mediated through a class of recognition sites associated with the gamma-aminobutyric acid A receptor. A second class of benzodiazepine binding sites is found in virtually all mammalian peripheral tissues and is therefore called the peripheral type benzodiazepine receptor (PBR). 2. The first section of this review describes the tissue and subcellular distribution of the PBR in mammalian tissues and analyzes its many putative endogenous ligands. 3. The next section deals with the pharmacological, structural and molecular characterization of the PBR that has taken place in the past few years. 4. The final section describes the possible physiological role(s) of the PBR and identifies future work that would help deepen our understanding of the PBR and its function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378234     DOI: 10.1016/s0306-3623(96)00473-9

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  14 in total

Review 1.  The peripheral benzodiazepine receptors: a review.

Authors:  A Beurdeley-Thomas; L Miccoli; S Oudard; B Dutrillaux; M F Poupon
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands.

Authors:  N Cinone; H D Hötje; A Carotti
Journal:  J Comput Aided Mol Des       Date:  2000-11       Impact factor: 3.686

Review 3.  Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope?

Authors:  Pooneh Salari; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

4.  Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.

Authors:  Florence Dzierszinski; Alexandra Coppin; Marlene Mortuaire; Etienne Dewailly; Christian Slomianny; Jean-Claude Ameisen; Frederic DeBels; Stanislas Tomavo
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

5.  Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa).

Authors:  Yota Fujimura; Yasuyuki Kimura; Fabrice G Siméon; Leah P Dickstein; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

6.  A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.

Authors:  Fang Guo; Shuo Wu; Justin Julander; Julia Ma; Xuexiang Zhang; John Kulp; Andrea Cuconati; Timothy M Block; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription.

Authors:  Hui-Jie Wang; Jinjiang Fan; Vassilios Papadopoulos
Journal:  Cell Tissue Res       Date:  2012-08-07       Impact factor: 5.249

8.  Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Authors:  Yong-Sok Lee; Fabrice G Siméon; Emmanuelle Briard; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2012-02-14       Impact factor: 4.418

9.  Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS).

Authors:  Filomena Mattner; Karine Mardon; Andrew Katsifis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-05       Impact factor: 9.236

10.  Brain-Gut Interactions in IBS.

Authors:  Jakub Fichna; Martin A Storr
Journal:  Front Pharmacol       Date:  2012-07-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.